
Accelerate Diagnostics AXDX
Quarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics ROA Ratio 2011-2025 | AXDX
Annual ROA Ratio Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.47 | -27.46 | -83.71 | -62.72 | -47.68 | -51.01 | -80.11 | -32.66 | -44.32 | -35.19 | -30.85 | -6.05 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.05 | -83.71 | -43.68 |
Quarterly ROA Ratio Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -91.35 | -111.68 | -96.25 | -117.2 | -140.48 | -106.39 | -71.64 | -99.1 | -89.21 | -80.73 | -87.75 | -80.53 | -89.54 | -87.06 | -83.71 | -79.34 | -74.46 | -69.37 | -62.72 | -58.82 | -55.55 | -52.6 | -47.68 | -48.68 | -50.36 | -50.93 | -51.01 | -57.5 | -64.78 | -73.23 | -80.11 | -70.08 | -57.23 | -44.46 | -32.66 | -35.77 | -40.36 | -43.25 | -44.32 | -43.64 | -39.75 | -36.77 | -35.19 | -25.74 | -45.8 | -45.55 | -52.18 | -50.18 | -28.26 | -19.17 | -13.53 | -6.88 | 0.65 | -6.87 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.65 | -140.48 | -59.75 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.36 | -4.05 % | $ 176 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | $ 17.05 | -2.15 % | $ 99.4 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.63 | -2.11 % | $ 2.07 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 221.54 | -1.96 % | $ 40.2 B | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 38.85 | 2.32 % | $ 1.08 B | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
Danaher Corporation
DHR
|
5.03 | $ 227.08 | -2.28 % | $ 166 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.92 | -6.58 % | $ 338 M | ||
|
DexCom
DXCM
|
8.64 | $ 66.91 | -2.94 % | $ 25.8 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 20.44 | 3.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
-45.6 | $ 105.26 | 4.46 % | $ 4.15 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-58.14 | $ 3.59 | -25.21 % | $ 115 K | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.58 | 0.21 % | $ 18.8 B | ||
|
Co-Diagnostics
CODX
|
-37.07 | $ 0.34 | -2.96 % | $ 9.98 M | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 27.13 | 0.26 % | $ 820 M | ||
|
Guardant Health
GH
|
-29.37 | $ 102.09 | 0.7 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Koninklijke Philips N.V.
PHG
|
10.73 | $ 26.6 | -1.52 % | $ 20 B | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-19.4 | $ 134.29 | -1.58 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
0.29 | $ 192.57 | -0.96 % | $ 9.89 B | ||
|
Quidel Corporation
QDEL
|
43.3 | $ 28.79 | -2.93 % | $ 1.21 B | ||
|
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 182.21 | 0.35 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 7.94 | -1.0 % | $ 1.03 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 263.51 | -0.46 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 186.28 | -1.92 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | $ 701.07 | -0.91 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 66.11 | 4.76 % | $ 4.57 B | ||
|
Agilent Technologies
A
|
11.3 | $ 139.44 | -2.4 % | $ 42.4 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.55 | -1.07 % | $ 5.86 M | ||
|
Bioventus
BVS
|
-19.27 | $ 7.59 | 2.29 % | $ 475 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
26.64 | $ 1 395.23 | -1.85 % | $ 29.6 B | ||
|
Myriad Genetics
MYGN
|
-12.39 | $ 7.26 | -0.62 % | $ 658 M | ||
|
ENDRA Life Sciences
NDRA
|
-258.47 | $ 5.47 | -7.6 % | $ 2.94 M |